Alzheimer's Disease: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities

Authors:

Thimmaiah Govindaraju

Brand: Royal Society for Chemistry

ISBN: 9781839162305

1,259.94 zł

1,133.94 zł Save 126.00 zł Tax included

Lowest price within 30 days before promotion: 1,133.94 zł

Quantity

Available in 4-6 weeks

Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Alzheimer-s disease is an increasingly common form of dementia and despite rising interest in discovery of novel treatments and investigation into aetiology, there are no currently approved treatments that directly tackle the causes of the condition. Due to its multifactorial pathogenesis, current treatments are directed against symptoms and even precise diagnosis remains difficult as the majority of cases are diagnosed symptomatically and usually confirmed only by autopsy. Alzheimer-s Disease:: Recent Findings in Pathophysiology, Diagnostic and Therapeutic Modalities provides a comprehensive overview from aetiology and neurochemistry to diagnosis, evaluation and management of Alzheimers disease, and latest therapeutic approaches. Intended to provide an introduction to all aspects of the disease and latest developments, this book is ideal for students, postgraduates and researchers in neurochemistry, neurological drug discovery and Alzheimer-s disease.

Product Details

Brand Royal Society for Chemistry

Reference 92658

EAN13 9781839162305

ISBN 9781839162305

Data sheet

Publication date: 2022
Issue number: 1
Cover: hard cover
Pages count: 694
Dimensions (mm): 156.00 x 234.00
Weight (g): 1143

Alzheimer-s is a Multifactorial Disease; The Genetic and Biochemical Basis of Alzheimer-s Disease; Alzheimer-s Disease Pathology with Tau Perspective; Structural Insights into the Amyloidogenic A? and Tau Species in Alzheimers Disease Pathophysiology:: Defining Functional Motifs For Therapeutic Interventions; Structural Insights on Aggregation Species of A? and Tau and their Implications in Alzheimer-s Disease; Aggregation Species of Amyloid-? and Tau Oligomers in Alzheimer-s Disease:: Role in Therapeutics and Diagnostics; Role of Metal Ions in Alzheimer-s Disease:: Mechanistic Aspects Contributing to Neurotoxicity; Microglial Blockade of the Amyloid Cascade:: A New Therapeutic Frontier; Post-translational Modifications and Alzheimer-s Disease; Autophagy:: Role in Alzheimer-s Disease Pathophysiology and Therapeutic Avenues; Transmission of Pathogenic Proteins and Role of Microbial Infection in Alzheimer-s Disease Pathology; The Role of Gut Microbiome in Alzheimer-s Disease and Therapeutic Strategies; Molecular Probes for the Diagnosis of Alzheimer-s Disease with Implications for Multiplexed and Multimodal Strategies; Circulating Biomarkers for the Diagnosis of Alzheimer-s Disease; Lactoferrin:: A Potential Theranostic Candidate for Alzheimer-s Disease; Multifunctional Inhibitors of Multifaceted A? Toxicity of Alzheimer-s Disease; Tau-targeting Therapeutic Strategies for Alzheimers Disease; Computational Development of Alzheimer-s Therapeutics and Diagnostics; Targeted Protein Degradation as a Therapeutic Avenue for Alzheimers Disease; Cell-based Therapy for Alzheimer-s Disease; Experimental Models to Study Alzheimer-s Disease; Ethnic and Racial Differences in the Pathophysiology of Alzheimers Disease